Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Complement system biomarkers in epilepsy.

Kopczynska M, Zelek WM, Vespa S, Touchard S, Wardle M, Loveless S, Thomas RH, Hamandi K, Morgan BP.

Seizure. 2018 May 24;60:1-7. doi: 10.1016/j.seizure.2018.05.016. [Epub ahead of print]

PMID:
29857269
2.

Need for improved public health protection of young people wanting body piercing: evidence from a look-back exercise at a piercing and tattooing premises with poor hygiene practices, Wales (UK) 2015.

Perry M, Lewis H, Thomas DR, Mason B, Richardson G.

Epidemiol Infect. 2018 Apr 30:1-7. doi: 10.1017/S0950268818001024. [Epub ahead of print]

PMID:
29708089
3.

Valproate: life-saving, life-changing.

Thomas RH.

Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s1-s8. doi: 10.7861/clinmedicine.18-2-s1.

PMID:
29700085
4.

Educational attainment of children born to mothers with epilepsy.

Lacey AS, Pickrell WO, Thomas RH, Kerr MP, White CP, Rees MI.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):736-740. doi: 10.1136/jnnp-2017-317515. Epub 2018 Mar 27.

PMID:
29588327
5.

Chemical composition of kale as influenced by dry vermicast, potassium humate and volcanic minerals.

Abbey L, Pham TH, Annan N, Leke-Aladekoba A, Thomas RH.

Food Res Int. 2018 May;107:726-737. doi: 10.1016/j.foodres.2018.03.010. Epub 2018 Mar 7.

PMID:
29580540
6.

Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.

Whelan CD, Altmann A, Botía JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, França W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodríguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargalló N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blümcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kälviäinen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O'Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM.

Brain. 2018 Feb 1;141(2):391-408. doi: 10.1093/brain/awx341.

7.

High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.

Hamdan FF, Myers CT, Cossette P, Lemay P, Spiegelman D, Laporte AD, Nassif C, Diallo O, Monlong J, Cadieux-Dion M, Dobrzeniecka S, Meloche C, Retterer K, Cho MT, Rosenfeld JA, Bi W, Massicotte C, Miguet M, Brunga L, Regan BM, Mo K, Tam C, Schneider A, Hollingsworth G; Deciphering Developmental Disorders Study, FitzPatrick DR, Donaldson A, Canham N, Blair E, Kerr B, Fry AE, Thomas RH, Shelagh J, Hurst JA, Brittain H, Blyth M, Lebel RR, Gerkes EH, Davis-Keppen L, Stein Q, Chung WK, Dorison SJ, Benke PJ, Fassi E, Corsten-Janssen N, Kamsteeg EJ, Mau-Them FT, Bruel AL, Verloes A, Õunap K, Wojcik MH, Albert DVF, Venkateswaran S, Ware T, Jones D, Liu YC, Mohammad SS, Bizargity P, Bacino CA, Leuzzi V, Martinelli S, Dallapiccola B, Tartaglia M, Blumkin L, Wierenga KJ, Purcarin G, O'Byrne JJ, Stockler S, Lehman A, Keren B, Nougues MC, Mignot C, Auvin S, Nava C, Hiatt SM, Bebin M, Shao Y, Scaglia F, Lalani SR, Frye RE, Jarjour IT, Jacques S, Boucher RM, Riou E, Srour M, Carmant L, Lortie A, Major P, Diadori P, Dubeau F, D'Anjou G, Bourque G, Berkovic SF, Sadleir LG, Campeau PM, Kibar Z, Lafrenière RG, Girard SL, Mercimek-Mahmutoglu S, Boelman C, Rouleau GA, Scheffer IE, Mefford HC, Andrade DM, Rossignol E, Minassian BA, Michaud JL.

Am J Hum Genet. 2017 Nov 2;101(5):664-685. doi: 10.1016/j.ajhg.2017.09.008.

8.

Gamification of Medication Adherence in Epilepsy.

Abdul Rahim MI, Thomas RH.

Seizure. 2017 Nov;52:11-14. doi: 10.1016/j.seizure.2017.09.008. Epub 2017 Sep 14. Review.

PMID:
28934624
9.

Epilepsy treatment priorities: answering the questions that matter.

Hughes EG, Thomas RH.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):999-1001. doi: 10.1136/jnnp-2016-315135. Epub 2017 Jun 1. No abstract available.

PMID:
28572278
10.

On the road again: assessing driving ability in patients with neurological conditions.

Handley JD, Thomas RH, McKenna P, Hughes TAT.

Pract Neurol. 2017 Jun;17(3):203-206. doi: 10.1136/practneurol-2017-001601. Epub 2017 May 4. Review.

PMID:
28473607
11.

Ultra-rare genetic variation in common epilepsies: a case-control sequencing study.

Epi4K consortium; Epilepsy Phenome/Genome Project.

Lancet Neurol. 2017 Feb;16(2):135-143. doi: 10.1016/S1474-4422(16)30359-3.

PMID:
28102150
12.

What can rare variant genetics tell us about cognition and intellectual difficulties?

Thomas RH, Robertson NP.

J Neurol. 2016 Dec;263(12):2565-2566. No abstract available.

13.

Generalized Epilepsy and Myoclonic Seizures in 22q11.2 Deletion Syndrome.

Strehlow V, Swinkels ME, Thomas RH, Rapps N, Syrbe S, Dorn T, Lemke JR.

Mol Syndromol. 2016 Sep;7(4):239-246. Epub 2016 Aug 24.

14.

Sudden death in epilepsy: Insights from the last 25 years.

Jones LA, Thomas RH.

Seizure. 2017 Jan;44:232-236. doi: 10.1016/j.seizure.2016.10.002. Epub 2016 Oct 14. Review.

15.

Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role.

Waller R, Woodroofe MN, Wharton SB, Ince PG, Francese S, Heath PR, Cudzich-Madry A, Thomas RH, Rounding N, Sharrack B, Simpson JE.

J Neuroimmunol. 2016 Oct 15;299:139-146. doi: 10.1016/j.jneuroim.2016.09.010. Epub 2016 Sep 14.

PMID:
27725112
16.

The consequences of valproate exposure in utero.

Thomas RH, Robertson NP.

J Neurol. 2016 Sep;263(9):1887-9. doi: 10.1007/s00415-016-8269-y. No abstract available.

17.

Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy.

Fry AE, Rees E, Thompson R, Mantripragada K, Blake P, Jones G, Morgan S, Jose S, Mugalaasi H, Archer H, McCann E, Clarke A, Taylor C, Davies S, Gibbon F, Te Water Naude J, Hartley L, Thomas G, White C, Natarajan J, Thomas RH, Drew C, Chung SK, Rees MI, Holmans P, Owen MJ, Kirov G, Pilz DT, Kerr MP.

BMC Med Genet. 2016 Apr 26;17(1):34. doi: 10.1186/s12881-016-0294-2.

18.

Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016.

Williams CJ, Thomas RH, Pickersgill TP, Lyons M, Lowe G, Stiff RE, Moore C, Jones R, Howe R, Brunt H, Ashman A, Mason BW.

Euro Surveill. 2016;21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30119.

19.

An axillofemoral bypass graft transgressing the chest wall.

Levena Skervin A, Thomas RH, Sritharan K.

Clin Case Rep. 2015 Nov 11;4(1):32-4. doi: 10.1002/ccr3.386. eCollection 2016 Jan.

20.

Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy.

Leu C, Balestrini S, Maher B, Hernández-Hernández L, Gormley P, Hämäläinen E, Heggeli K, Schoeler N, Novy J, Willis J, Plagnol V, Ellis R, Reavey E, O'Regan M, Pickrell WO, Thomas RH, Chung SK, Delanty N, McMahon JM, Malone S, Sadleir LG, Berkovic SF, Nashef L, Zuberi SM, Rees MI, Cavalleri GL, Sander JW, Hughes E, Helen Cross J, Scheffer IE, Palotie A, Sisodiya SM.

EBioMedicine. 2015 Jul 10;2(9):1063-70. doi: 10.1016/j.ebiom.2015.07.005. eCollection 2015 Sep.

21.

Epilepsy and bipolar disorder.

Knott S, Forty L, Craddock N, Thomas RH.

Epilepsy Behav. 2015 Nov;52(Pt A):267-74. doi: 10.1016/j.yebeh.2015.07.003. Epub 2015 Aug 25. Review.

PMID:
26316422
22.

Testing new treatments for paediatric epilepsies.

Thomas RH, Robertson NP.

J Neurol. 2015 Aug;262(8):1996-8. doi: 10.1007/s00415-015-7857-6. No abstract available.

PMID:
26194200
23.

Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.

Thomas RH, Luthin DR.

Pharmacotherapy. 2015 Jun;35(6):613-30. doi: 10.1002/phar.1594. Epub 2015 May 27. Review.

PMID:
26016701
24.

Epilepsy and deprivation, a data linkage study.

Pickrell WO, Lacey AS, Bodger OG, Demmler JC, Thomas RH, Lyons RA, Smith PE, Rees MI, Kerr MP.

Epilepsia. 2015 Apr;56(4):585-91. doi: 10.1111/epi.12942. Epub 2015 Mar 2.

25.

CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.

Thomas RH, Zhang LM, Carvill GL, Archer JS, Heavin SB, Mandelstam SA, Craiu D, Berkovic SF, Gill DS, Mefford HC, Scheffer IE; EuroEPINOMICS RES Consortium.

Neurology. 2015 Mar 3;84(9):951-8. doi: 10.1212/WNL.0000000000001305. Epub 2015 Feb 11.

26.

Hyperconnectivity in juvenile myoclonic epilepsy: a network analysis.

Caeyenberghs K, Powell HW, Thomas RH, Brindley L, Church C, Evans J, Muthukumaraswamy SD, Jones DK, Hamandi K.

Neuroimage Clin. 2014 Nov 27;7:98-104. doi: 10.1016/j.nicl.2014.11.018. eCollection 2015.

27.

The impact of the media on the decision of parents in South Wales to accept measles-mumps-rubella (MMR) immunization.

Walsh S, Thomas DR, Mason BW, Evans MR.

Epidemiol Infect. 2015 Feb;143(3):550-60. doi: 10.1017/S0950268814000752.

PMID:
25600667
28.

Oral disease-modifying therapies for relapsing-remitting multiple sclerosis.

Thomas RH, Wakefield RA.

Am J Health Syst Pharm. 2015 Jan 1;72(1):25-38. doi: 10.2146/ajhp140023. Review.

PMID:
25511835
29.

Hyperekplexia: overexcitable and underdiagnosed.

Thomas RH.

Dev Med Child Neurol. 2015 Apr;57(4):313. doi: 10.1111/dmcn.12638. Epub 2014 Nov 19. No abstract available.

30.

Novel auto-antibody syndromes.

Thomas RH, Robertson NP.

J Neurol. 2014 Oct;261(10):2043-5. doi: 10.1007/s00415-014-7497-2. No abstract available.

PMID:
25223959
31.

Epilepsy prevalence and socioeconomic deprivation in England.

Steer S, Pickrell WO, Kerr MP, Thomas RH.

Epilepsia. 2014 Oct;55(10):1634-41. doi: 10.1111/epi.12763. Epub 2014 Sep 2.

32.

Rasmussen's aneurysm.

Nzekwu E, Hnatiuk BD, Thomas RH.

Br J Hosp Med (Lond). 2014 Jul;75(7):410-1. doi: 10.12968/hmed.2014.75.7.410. No abstract available.

PMID:
25040524
33.

Harmonizing influenza primary-care surveillance in the United Kingdom: piloting two methods to assess the timing and intensity of the seasonal epidemic across several general practice-based surveillance schemes.

Green HK, Charlett A, Moran-Gilad J, Fleming D, Durnall H, Thomas DR, Cottrell S, Smyth B, Kearns C, Reynolds AJ, Smith GE, Elliot AJ, Ellis J, Zambon M, Watson JM, McMenamin J, Pebody RG.

Epidemiol Infect. 2015 Jan;143(1):1-12. doi: 10.1017/S0950268814001757. Epub 2014 Jul 15. Review.

PMID:
25023603
34.

Ethnicity can predict GLRA1 genotypes in hyperekplexia.

Thomas RH, Drew CJ, Wood SE, Hammond CL, Chung SK, Rees MI.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):341-3. doi: 10.1136/jnnp-2014-307903. Epub 2014 Jun 26.

PMID:
24970905
35.

A comprehensive neuropsychological description of cognition in drug-refractory juvenile myoclonic epilepsy.

Thomas RH, Walsh J, Church C, Sills GJ, Marson AG, Baker GA, Rees MI.

Epilepsy Behav. 2014 Jul;36:124-9. doi: 10.1016/j.yebeh.2014.04.027. Epub 2014 Jun 2.

PMID:
24938758
36.

Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy.

Koepp MJ, Thomas RH, Wandschneider B, Berkovic SF, Schmidt D.

Expert Rev Neurother. 2014 Jul;14(7):819-31. doi: 10.1586/14737175.2014.928203. Epub 2014 Jun 14. Review.

PMID:
24931665
37.

Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsy.

Walsh J, Thomas RH, Church C, Rees MI, Marson AG, Baker GA.

Epilepsy Behav. 2014 Jun;35:72-7. doi: 10.1016/j.yebeh.2014.03.026. Epub 2014 May 13.

PMID:
24820514
38.

Seasonal accumulation of acetylated triacylglycerols by a freeze-tolerant insect.

Marshall KE, Thomas RH, Roxin A, Chen EK, Brown JC, Gillies ER, Sinclair BJ.

J Exp Biol. 2014 May 1;217(Pt 9):1580-7. doi: 10.1242/jeb.099838.

39.

The hidden genetics of epilepsy-a clinically important new paradigm.

Thomas RH, Berkovic SF.

Nat Rev Neurol. 2014 May;10(5):283-92. doi: 10.1038/nrneurol.2014.62. Epub 2014 Apr 15. Review.

PMID:
24733163
40.

A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes.

Johnston AJ, Kang JQ, Shen W, Pickrell WO, Cushion TD, Davies JS, Baer K, Mullins JGL, Hammond CL, Chung SK, Thomas RH, White C, Smith PEM, Macdonald RL, Rees MI.

Neurobiol Dis. 2014 Apr;64:131-141. doi: 10.1016/j.nbd.2013.12.013. Epub 2014 Jan 7.

41.

Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010.

Pickrell WO, Lacey AS, Thomas RH, Lyons RA, Smith PE, Rees MI.

Seizure. 2014 Jan;23(1):77-80. doi: 10.1016/j.seizure.2013.09.007. Epub 2013 Sep 19.

42.

New hyperekplexia mutations provide insight into glycine receptor assembly, trafficking, and activation mechanisms.

Bode A, Wood SE, Mullins JG, Keramidas A, Cushion TD, Thomas RH, Pickrell WO, Drew CJ, Masri A, Jones EA, Vassallo G, Born AP, Alehan F, Aharoni S, Bannasch G, Bartsch M, Kara B, Krause A, Karam EG, Matta S, Jain V, Mandel H, Freilinger M, Graham GE, Hobson E, Chatfield S, Vincent-Delorme C, Rahme JE, Afawi Z, Berkovic SF, Howell OW, Vanbellinghen JF, Rees MI, Chung SK, Lynch JW.

J Biol Chem. 2013 Nov 22;288(47):33745-59. doi: 10.1074/jbc.M113.509240. Epub 2013 Oct 9.

43.

The importance of the experiences of initial diagnosis and treatment failure when switching antiepileptic drugs.

Thomas RH, Mullins JM, Hammond CL, Smith PE, Kerr MP.

Epilepsy Behav. 2013 Dec;29(3):492-6. doi: 10.1016/j.yebeh.2013.08.025. Epub 2013 Oct 2.

PMID:
24094841
44.

Facial indices of north and South Indian adults: reliability in stature estimation and sexual dimorphism.

Lc P, S B, As D, H M, Rh T, Ks S.

J Clin Diagn Res. 2013 Aug;7(8):1540-2. doi: 10.7860/JCDR/2013/5497.3204. Epub 2013 Aug 1.

45.

Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.

Thomas RH, Chung SK, Wood SE, Cushion TD, Drew CJ, Hammond CL, Vanbellinghen JF, Mullins JG, Rees MI.

Brain. 2013 Oct;136(Pt 10):3085-95. doi: 10.1093/brain/awt207. Epub 2013 Sep 11.

PMID:
24030948
47.

Preapproval and postapproval availability of published comparative efficacy research on biological agents.

Thomas RH, Freeman MK, Hughes PJ.

Am J Health Syst Pharm. 2013 Jul 15;70(14):1250-5. doi: 10.2146/ajhp120515.

PMID:
23820463
48.

The expression of limb gap genes in the mite Archegozetes longisetosus reveals differential patterning mechanisms in chelicerates.

Barnett AA, Thomas RH.

Evol Dev. 2013 Jul-Aug;15(4):280-92. doi: 10.1111/ede.12038.

PMID:
23809702
49.

Subclinical infection and asymptomatic carriage of gastrointestinal zoonoses: occupational exposure, environmental pathways, and the anonymous spread of disease.

Quilliam RS, Cross P, Williams AP, Edwards-Jones G, Salmon RL, Rigby D, Chalmers RM, Thomas DR, Jones DL.

Epidemiol Infect. 2013 Oct;141(10):2011-21. doi: 10.1017/S0950268813001131. Epub 2013 May 10. Review.

PMID:
23659675

Supplemental Content

Loading ...
Support Center